News & Updates

COVID-19 patients most infectious in 1st week of symptom onset

10 Jan 2021 by

People infected with SARS-CoV-2 appear to be highly infectious within the first week following symptom onset, with the highest viral load and live virus detected during this period, according to a systematic review and meta-analysis of three human coronaviruses.

COVID-19 patients most infectious in 1st week of symptom onset

10 Jan 2021

First-line lorlatinib trumps crizotinib for advanced ALK+ lung cancer

07 Jan 2021 by

The novel third-generation ALK* inhibitor lorlatinib outdid the first-generation inhibitor crizotinib as treatment for previously untreated advanced ALK+ non-small-cell lung cancer (NSCLC), according to the interim results of the CROWN trial.

First-line lorlatinib trumps crizotinib for advanced ALK+ lung cancer

07 Jan 2021

Decannulation delayed by chronic neurological conditions in preemies with BPD

06 Jan 2021

Chronic neurologic conditions delay the time to tracheostomy decannulation among premature infants with severe bronchopulmonary dysplasia (BPD), a new study has found.

Decannulation delayed by chronic neurological conditions in preemies with BPD

06 Jan 2021

Poor physical performance raises red flag for CV hospitalization in COPD patients

06 Jan 2021

Patients with chronic obstructive pulmonary disorder (COPD) who perform poorly on the 6-min walk test (6MWT) are at increased risk of cardiovascular (CV)-related hospitalizations, a study has found.

Poor physical performance raises red flag for CV hospitalization in COPD patients

06 Jan 2021

ICS use in COPD, asthma does not affect COVID-19-related mortality

05 Jan 2021 by

Regular use of inhaled corticosteroids (ICS) for the treatment of chronic obstructive pulmonary disease (COPD) or asthma does not appear to affect COVID-19-related mortality, an observational study from England showed.

ICS use in COPD, asthma does not affect COVID-19-related mortality

05 Jan 2021

Acid reflux a gateway to multiple diseases

05 Jan 2021 by

Gastroesophageal reflux disease (GERD) may predispose patients to developing other diseases, as reported in a study. For the most part, it puts the whammy on chronic obstructive pulmonary disorder, doubling exacerbations, and raises the risk of oesophageal adenocarcinoma.

Acid reflux a gateway to multiple diseases

05 Jan 2021

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

04 Jan 2021 by

In a fully remote, preliminary study evaluating adult outpatients with mild COVID-19, the likelihood of clinical deterioration* over 15 days was lower among those treated with fluvoxamine – an SSRI** and a strong σ-1 receptor (S1R) agonist – compared with those receiving placebo.

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

04 Jan 2021

Dihydropyridine CCBs keep users from catching tuberculosis

02 Jan 2021 by

Dihydropyridine calcium channel blockers (CCBs), commonly used to manage hypertension, also help lower the risk of developing tuberculosis, as shown in a study.

Dihydropyridine CCBs keep users from catching tuberculosis

02 Jan 2021

SARS-CoV-2 does not transmit from mother to child during pregnancy

25 Dec 2020 by

A new study finds no evidence of vertical transmissions of SARS-CoV-2 from mother to child during pregnancy, but there appears to be limited transplacental transfer of anti-SARS-CoV-2 antibodies to the neonates in utero.

SARS-CoV-2 does not transmit from mother to child during pregnancy

25 Dec 2020

High-dose flu vaccine no better than standard-dose in reducing death, CV hospitalization

21 Dec 2020 by

Patients with high cardiovascular (CV) risk who received a high-dose trivalent influenza vaccine over three influenza seasons did not have a lower risk of cardiopulmonary hospitalization or death compared with those who received a standard-dose quadrivalent vaccine, according to the INVESTED* trial presented at AHA 2020.

High-dose flu vaccine no better than standard-dose in reducing death, CV hospitalization

21 Dec 2020

News & Updates

Filter by Specialty:

Specialty:

COVID-19 patients most infectious in 1st week of symptom onset

COVID-19 patients most infectious in 1st week of symptom onset

First-line lorlatinib trumps crizotinib for advanced ALK+ lung cancer

First-line lorlatinib trumps crizotinib for advanced ALK+ lung cancer

Decannulation delayed by chronic neurological conditions in preemies with BPD

Decannulation delayed by chronic neurological conditions in preemies with BPD

Poor physical performance raises red flag for CV hospitalization in COPD patients

Poor physical performance raises red flag for CV hospitalization in COPD patients

ICS use in COPD, asthma does not affect COVID-19-related mortality

ICS use in COPD, asthma does not affect COVID-19-related mortality

Acid reflux a gateway to multiple diseases

Acid reflux a gateway to multiple diseases

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

Dihydropyridine CCBs keep users from catching tuberculosis

Dihydropyridine CCBs keep users from catching tuberculosis

SARS-CoV-2 does not transmit from mother to child during pregnancy

SARS-CoV-2 does not transmit from mother to child during pregnancy

High-dose flu vaccine no better than standard-dose in reducing death, CV hospitalization

High-dose flu vaccine no better than standard-dose in reducing death, CV hospitalization